SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving discussion, with traders debating whether security concerns and crypto outflows, leveraged liquidations, or broader risk-off pressure are behind the decline. Bears warn of more downside, while bulls describe the drop as oversold and a buying opportunity.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep decline alongside a broad crypto selloff is driving discussion, with traders pointing to Bitcoins weakness and leveraged liquidations while debating whether the drop marks capitulation or further downside. Some are buying the dip, while others cite XRPs supply dynamics, Ripple-related concerns, and a lack of fresh catalysts as reasons for caution.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,215,668.80579185. The last known price of Ethereum is 1,929.81008702 USD and is down -4.05 over the last 24 hours. It is currently trading on 14342 active market(s) with $15,325,408,368.61 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is caught in a broader crypto selloff, with traders pointing to hot inflation data, hawkish rate expectations, and leveraged liquidations as pressure on the market. The conversation is largely bearish, with many expecting further declines, while some traders view the drop as a buying opportunity or anticipate a rebound.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summits pending FDA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer is driving attention, with traders treating the PDUFA as a high-stakes binary event. Bulls point to the progression-free survival benefit and favorable later survival trends, while bears focus on the trials failure to meet statistical significance for overall survival and the FDAs stated concern about that endpoint.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 637,493,507.45679271 with 591,519,914.8768357 in circulation. The last known price of Solana is 77.75210106 USD and is down -4.52 over the last 24 hours. It is currently trading on 1189 active market(s) with $3,771,510,230.13 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

A broad crypto selloff, with Bitcoin weakness and reports of leveraged liquidations, is driving attention to Solanas sharp decline. Traders are split between expecting further downside and viewing the pullback as a buying opportunity, with some continuing to accumulate and stake SOL.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,140,678.86417527 in circulation. The last known price of Hedera is 0.06118377 USD and is down -3.83 over the last 24 hours. It is currently trading on 468 active market(s) with $73,346,897.90 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

HBAR is drawing attention amid a steep pullback and volatile trading, with many traders calling it a buying opportunity while others blame dilution, weak revenue, and tokenomics for persistent selling pressure. The community is split between dip buyers and holders who say the project has underperformed despite enterprise partnerships and adoption claims.

Quant (QNT) is a cryptocurrency and operates on the Ethereum platform. Quant has a current supply of 14,881,364 with 12,072,738 in circulation. The last known price of Quant is 159.21664083 USD and is down -1.76 over the last 24 hours. It is currently trading on 414 active market(s) with $110,625,382.40 traded over the last 24 hours. More information can be found at https://quant.network/.

Quant

QNTs sharp swingsfrom a steep pullback to a rapid reboundare driving debate over whether the move reflects a short squeeze in a thin market or a durable recovery. Bulls point to Quants planned Clearing House and tokenized-banking rollout in 2027 as a longer-term catalyst, while cautious traders question whether the tokens price will benefit before the network goes live.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Speculation that Johnson & Johnson could acquire Sellas Life Sciences is a major topic, with traders pointing to J&Js oncology ambitions and alleged executive connections; no deal is confirmed. The discussion also highlights J&Js defensive appeal and recent strength, while some traders remain cautious after a mixed earnings reaction tied to slower MedTech growth.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land, and sea domains. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne, and cyber domains. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

Reports that a failed update to an L3Harris-managed FAA communications network caused an air-traffic outage are driving attention. Traders are debating the companys responsibility and possible legal fallout, while claims of a cyberattack remain speculation and some question whether L3Harris caused the failure.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta is drawing attention after a nationwide FAA ground stop caused by an air-traffic-control communications outage disrupted flights, with delays and cancellations continuing after departures resumed. Traders debate the short-term operational and financial impact; some view it as a temporary disruption, while others worry about ongoing cancellations and the reliability of aging systems.

statis crypto Watchlist

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MVMDF 

🔥 FDA PCAC MEETING IS THIS WEEK: July 23-24, 2026 — the FDA Pharmacy Compounding Advisory Committee reviews BPC-157, KPV, TB-500, and MOTS-C for 503A compounding eligibility. $MVMD $MVMDF $20MP has Quicksome™ sublingual formulations of BPC-157, GHK-Cu, KPV, SNAP-8, and retatrutide ALREADY COMPLETED. The stock is up 220% YoY. This is the catalyst week. DYOR. #BPC157 #FDA #Peptides #MVMD

Adnan

Rob Mininni

Tim Small

StockTwits for iOS

Mountain Valley MD Holdings Inc

 

🔥 FDA PCAC MEETING IS THIS WEEK: July 23-24, 2026 — the FDA Pharmacy Compounding Advisory Committee reviews BPC-157, KPV, TB-500, and MOTS-C for 503A compounding eligibility. $MVMD 

 $20MP has Quicksome™ sublingual formulations of BPC-157, GHK-Cu, KPV, SNAP-8, and retatrutide ALREADY COMPLETED. The stock is up 220% YoY. This is the catalyst week. DYOR. 